头颈癌当前及新出现的诊断、预后和预测生物标志物
Current and Emerging Diagnostic, Prognostic, and Predictive Biomarkers in Head and Neck Cancer.
作者信息
Eberly Hänel W, Sciscent Bao Y, Lorenz F Jeffrey, Rettig Eleni M, Goyal Neerav
机构信息
Department of Otolaryngology Head and Neck Surgery, Penn State Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, PA 17033, USA.
Department of Otolaryngology Head and Neck Surgery, Brigham and Women's Hospital, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02108, USA.
出版信息
Biomedicines. 2024 Feb 10;12(2):415. doi: 10.3390/biomedicines12020415.
Abstract
Head and neck cancers (HNC) are a biologically diverse set of cancers that are responsible for over 660,000 new diagnoses each year. Current therapies for HNC require a comprehensive, multimodal approach encompassing resection, radiation therapy, and systemic therapy. With an increased understanding of the mechanisms behind HNC, there has been growing interest in more accurate prognostic indicators of disease, effective post-treatment surveillance, and individualized treatments. This chapter will highlight the commonly used and studied biomarkers in head and neck squamous cell carcinoma.
摘要
头颈癌（HNC）是一组生物学特性多样的癌症，每年有超过66万例新诊断病例。目前针对头颈癌的治疗需要采用包括手术切除、放射治疗和全身治疗在内的综合多模式方法。随着对头颈癌背后机制的认识不断加深，人们对更准确的疾病预后指标、有效的治疗后监测和个体化治疗的兴趣日益浓厚。本章将重点介绍头颈鳞状细胞癌中常用和研究较多的生物标志物。
相似文献
1
Current and Emerging Diagnostic, Prognostic, and Predictive Biomarkers in Head and Neck Cancer.头颈癌当前及新出现的诊断、预后和预测生物标志物
Biomedicines. 2024 Feb 10;12(2):415. doi: 10.3390/biomedicines12020415.
2
A Current Update on Human Papillomavirus-Associated Head and Neck Cancers.人乳头瘤病毒相关性头颈部癌症的最新研究进展。
Viruses. 2019 Oct 9;11(10):922. doi: 10.3390/v11100922.
3
Emerging biomarkers in head and neck cancer in the era of genomics.基因组学时代头颈部癌症的新兴生物标志物。
Nat Rev Clin Oncol. 2015 Jan;12(1):11-26. doi: 10.1038/nrclinonc.2014.192. Epub 2014 Nov 18.
4
Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols.头颈部鳞状细胞癌复发模式，为制定个体化监测方案提供信息。
Cancer. 2023 Sep 15;129(18):2817-2827. doi: 10.1002/cncr.34823. Epub 2023 May 10.
5
Biomarker driven treatment of head and neck squamous cell cancer.生物标志物驱动的头颈部鳞状细胞癌治疗
Cancers Head Neck. 2017 Aug 29;2:6. doi: 10.1186/s41199-017-0025-1. eCollection 2017.
6
Liquid Biopsy in Head and Neck Cancer: Current Evidence and Future Perspective on Squamous Cell, Salivary Gland, Paranasal Sinus and Nasopharyngeal Cancers.头颈部癌的液体活检：关于鳞状细胞癌、唾液腺癌、鼻窦癌和鼻咽癌的当前证据及未来展望
Cancers (Basel). 2022 Jun 9;14(12):2858. doi: 10.3390/cancers14122858.
7
The Diagnostic and Prognostic Value of sIL-2R as an Immune Biomarker in Head and Neck Cancers.可溶性白细胞介素-2受体作为头颈部癌症免疫生物标志物的诊断和预后价值
Anticancer Res. 2016 Aug;36(8):4347-52.
8
Current evidence on the burden of head and neck cancers in Nigeria.尼日利亚头颈癌负担的当前证据。
Head Neck Oncol. 2009 May 28;1:14. doi: 10.1186/1758-3284-1-14.
9
Prevalence of comorbidities and effect on survival in survivors of human papillomavirus-related and human papillomavirus-unrelated head and neck cancer in the United States.美国 HPV 相关和 HPV 不相关头颈部癌症幸存者的合并症患病率及其对生存的影响。
Cancer. 2019 Jan 15;125(2):249-260. doi: 10.1002/cncr.31800. Epub 2018 Nov 16.
10
Identification and Complete Validation of Prognostic Gene Signatures for Human Papillomavirus-Associated Cancers: Integrated Approach Covering Different Anatomical Locations.针对 HPV 相关癌症的预后基因标志物的鉴定和全面验证：涵盖不同解剖部位的综合方法。
J Virol. 2021 Feb 24;95(6). doi: 10.1128/JVI.02354-20.
引用本文的文献
1
External validation of deep learning-derived 18F-FDG PET/CT delta biomarkers for loco-regional control in head and neck cancer.深度学习衍生的18F-FDG PET/CT增量生物标志物对头颈部癌局部区域控制的外部验证
Acta Oncol. 2025 Aug 30;64:1143-1151. doi: 10.2340/1651-226X.2025.43977.
2
Molecular Targets for Pharmacotherapy of Head and Neck Squamous Cell Carcinomas.头颈部鳞状细胞癌药物治疗的分子靶点
Curr Issues Mol Biol. 2025 Aug 1;47(8):609. doi: 10.3390/cimb47080609.
3
Salivary Extracellular Vesicles in Detection of Head and Neck Cancers: A Systematic Review.唾液细胞外囊泡在头颈部癌症检测中的应用：一项系统综述
Int J Nanomedicine. 2025 May 26;20:6757-6775. doi: 10.2147/IJN.S520288. eCollection 2025.
4
Predicting Early Death in Head and Neck Cancer-A Pilot Study.预测头颈癌早期死亡——一项试点研究
Cancers (Basel). 2025 Jan 17;17(2):302. doi: 10.3390/cancers17020302.
5
Early Alterations of Cytoskeletal Proteins Induced by Radiation Therapy in the Parenchymal Cells of Rat Major Salivary Glands: A Comparative Immunohistochemical Analysis.放射治疗诱导大鼠主要唾液腺实质细胞细胞骨架蛋白的早期改变：一项比较免疫组织化学分析
Cureus. 2024 Dec 13;16(12):e75634. doi: 10.7759/cureus.75634. eCollection 2024 Dec.
6
Biomarkers in head and neck squamous cell carcinoma: unraveling the path to precision immunotherapy.头颈部鳞状细胞癌中的生物标志物：揭示精准免疫治疗之路
Front Oncol. 2024 Oct 8;14:1473706. doi: 10.3389/fonc.2024.1473706. eCollection 2024.
7
Antibody-Drug Conjugates and Their Potential in the Treatment of Patients with Biliary Tract Cancer.抗体药物偶联物及其在胆管癌患者治疗中的潜力。
Cancers (Basel). 2024 Sep 30;16(19):3345. doi: 10.3390/cancers16193345.
8
Effect of different approaches of direct radiation on the surface structure and caries susceptibility of enamel.不同直接辐射方法对釉质表面结构和龋易感性的影响。
Sci Rep. 2024 Aug 30;14(1):20183. doi: 10.1038/s41598-024-71277-7.
9
The Next Chapter in Cancer Diagnostics: Advances in HPV-Positive Head and Neck Cancer.癌症诊断的新篇章：HPV 阳性头颈部癌症的进展。
Biomolecules. 2024 Jul 30;14(8):925. doi: 10.3390/biom14080925.
10
The Role of Biomarkers in HPV-Positive Head and Neck Squamous Cell Carcinoma: Towards Precision Medicine.生物标志物在人乳头瘤病毒阳性头颈部鳞状细胞癌中的作用：迈向精准医学
Diagnostics (Basel). 2024 Jul 7;14(13):1448. doi: 10.3390/diagnostics14131448.
本文引用的文献
1
Clinical outcomes of oropharyngeal squamous cell carcinoma stratified by human papillomavirus subtype: A systematic review and meta-analysis.根据人乳头瘤病毒亚型分层的口咽鳞状细胞癌的临床结局：系统评价和荟萃分析。
Oral Oncol. 2024 Jan;148:106644. doi: 10.1016/j.oraloncology.2023.106644. Epub 2023 Nov 24.
2
Significance of neutrophil to lymphocyte ratio as a predictor of outcome in head and neck cancer treated with definitive chemoradiation.中性粒细胞与淋巴细胞比值对头颈部癌根治性放化疗预后预测的意义
Rep Pract Oncol Radiother. 2023 Jul 25;28(3):389-398. doi: 10.5603/RPOR.a2023.0042. eCollection 2023.
3
Anti-Epstein-Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer.抗 Epstein-Barr 病毒 BNLF2b 用于鼻咽癌大规模筛查。
N Engl J Med. 2023 Aug 31;389(9):808-819. doi: 10.1056/NEJMoa2301496.
4
Molecular and biological factors in the prognosis of head and neck squamous cell cancer.头颈部鳞状细胞癌预后的分子和生物学因素。
Mol Biol Rep. 2023 Sep;50(9):7839-7849. doi: 10.1007/s11033-023-08611-1. Epub 2023 Jul 26.
5
p16 and pRb expression in laryngeal squamous cell carcinoma with and without infection by EBV or different genotypes of HPV: a retrospective study.伴有或不伴有EBV感染或不同基因型HPV感染的喉鳞状细胞癌中p16和pRb的表达：一项回顾性研究
Infect Agent Cancer. 2023 Jul 11;18(1):43. doi: 10.1186/s13027-023-00514-x.
6
Performance of Liquid Biopsy for Diagnosis and Surveillance of Human Papillomavirus-Associated Oropharyngeal Cancer.液体活检在人乳头瘤病毒相关口咽癌诊断和监测中的应用。
JAMA Otolaryngol Head Neck Surg. 2023 Nov 1;149(11):971-977. doi: 10.1001/jamaoto.2023.1937.
7
Long-term patient-reported outcomes after reconstructive surgery for head and neck cancer: A systematic review.头颈部癌症重建手术后的长期患者报告结局：系统评价。
Head Neck. 2023 Sep;45(9):2469-2477. doi: 10.1002/hed.27450. Epub 2023 Jul 4.
8
Lessons and Opportunities for Biomarker-Driven Radiation Personalization in Head and Neck Cancer.头颈部癌症中生物标志物驱动的放疗个体化的经验与机遇。
Semin Radiat Oncol. 2023 Jul;33(3):336-347. doi: 10.1016/j.semradonc.2023.03.013.
9
Correlation of Bcl-2 expression with prognosis and survival in patients with head and neck cancer: A systematic review and meta-analysis.Bcl-2 表达与头颈部癌症患者预后和生存的相关性：系统评价和荟萃分析。
Crit Rev Oncol Hematol. 2023 Jul;187:104021. doi: 10.1016/j.critrevonc.2023.104021. Epub 2023 May 19.
10
Relationship of HPV16 E6 seropositivity with circulating tumor tissue modified HPV16 DNA before head and neck cancer diagnosis.头颈部癌诊断前HPV16 E6血清阳性与循环肿瘤组织中修饰的HPV16 DNA的关系。
Oral Oncol. 2023 Jun;141:106417. doi: 10.1016/j.oraloncology.2023.106417. Epub 2023 May 4.
Zotero 插件